Biomarkers of aging are measurable biological indicators that reflect the functional state of aging more accurately than chronological age. They capture molecular, cellular, physiological, and functional changes associated with aging and age-related disease risk. Common biomarkers include DNA methylation patterns, telomere length, inflammatory markers, metabolic profiles, proteomic signatures, and physical performance metrics such as grip strength and gait speed. Effective aging biomarkers should be predictive, reproducible, minimally invasive, and responsive to interventions. They are essential tools for evaluating longevity therapies, monitoring healthspan, and stratifying individuals in clinical and population studies. Advances in multi-omics technologies and artificial intelligence have accelerated biomarker discovery, enabling integrated aging indices. Biomarkers of aging play a critical role in shifting healthcare from disease treatment to early risk prediction, preventive strategies, and personalized aging interventions.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom